The U.S. Food and Drug Administration (FDA) has cleared the first test to detect women with risk of severe preeclampsia, a leading cause of pregnancy-related illness and death in the United States, Thermo Fisher Scientific Inc said on Friday.
© 2025 Thomson/Reuters. All rights reserved.